By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Zealand Pharma A/S  

Smedeland 26 B

Glostrup    DK-2600  Denmark
Phone: 45-43-28-12-00 Fax: 45-43-28-12-12


SEARCH JOBS








Company News
Zealand Pharma  (ZEAL.CO) Starts Clinical Development Of A Multiple-Dose Version Of Its Stable Glucagon Analogue, ZP4207 5/20/2015 8:23:19 AM
Zealand Pharma  (ZEAL.CO) Announces Organizational And Management Changes 3/19/2015 7:50:38 AM
Zealand Pharma  (ZEAL.CO) And Helsinn Healthcare SA Announce The Advance Of Elsiglutide Into Phase IIB Development For The Prevention Of Chemotherapy-Induced Diarrhea 2/5/2015 7:50:17 AM
Helsinn Healthcare SA And Zealand Pharma  (ZEAL.CO) Announce The Advance Of Elsiglutide Into Phase 2B Development For The Prevention Of Chemotherapy-Induced Diarrhea 2/5/2015 7:20:15 AM
Zealand Pharma  (ZEAL.CO) Presented Danegaptide As A Case Study On An Innovative Novel Peptide Therapeutic At The 9th Annual Peptide Therapeutics Symposium In The U.S. 10/29/2014 7:39:06 AM
Notice Of Zealand Pharma  (ZEAL.CO)'s Interim Report For H1 2014 And Related Conference Call 8/18/2014 7:02:26 AM
Zealand Pharma  (ZEAL.CO) Reports Increased Lyxumia® Royalty Revenue For H1 2014 And Informs Of Status Update As Provided By Sanofi 7/31/2014 9:17:34 AM
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact 7/28/2014 9:06:40 AM
Zealand Pharma  (ZEAL.CO) Provides An Update On Activities Relating To Danegaptide For The Protection Of Cardiac Tissue Against Reperfusion Injuries 6/24/2014 9:05:23 AM
Zealand Pharma  (ZEAL.CO) Presented New Data On Two Novel Peptide Therapeutics From Its Preclinical Diabetes Pipeline At The American Diabetes Association 74th Scientific Sessions 6/17/2014 9:01:57 AM
12345678910...
//-->